UnitedHealth Could Get Worse Before It Gets Better
After a punishing first half of the year, UnitedHealth’s latest earnings report delivered another gut punch.
The stock, which had already been cut in half year-to-date by July 31, slid even further following the release.
Between deteriorating fundamentals, mounting regulatory pressure, and a brutal earnings revision, it’s fair to ask whether UnitedHealth finally hit bottom,
» Read more about: UnitedHealth Could Get Worse Before It Gets Better »
Read More
Tesla’s Wild Ride: How Low Could the EV Giant Go?
Shares of EV major Tesla (NASDAQ:TSLA) have been defying gravity for years, rewarding longtime shareholders with very remarkably healthy returns. This year, though, TSLA has retreated on a combination of weakening outlook and the growing controversies surrounding Elon Musk.
What’s pushing Tesla shares lower, and how much more could the EV giant fall if it can’t regain its footing?
» Read more about: Tesla’s Wild Ride: How Low Could the EV Giant Go? »
Read More
Is David’s Dividend Strategy Perfect For Today’s Market?
David Bahnsen – founder of The Bahnsen Group and author of The Case for Dividend Growth – centers his investment philosophy on dividend growth investing.
In his view, a fundamental mentality shift is needed where investors need to focus on the cash income their portfolio generates rather than obsessing over short-term market prices.
» Read more about: Is David’s Dividend Strategy Perfect For Today’s Market? »
Read More
Why Bill Ackman Bet $2.3 Billion That the Market Is Dead Wrong
In early 2025, billionaire investor Bill Ackman, CEO of Pershing Square Capital Management, revealed a substantial new position in Uber Technologies. By January, Pershing Square had accumulated 30.3 million Uber shares, a ~1.4% stake worth about $2.3 billion.
Ackman described Uber as “one of the best-managed and highest-quality businesses in the world,” yet still “available at a massive discount to its intrinsic value.”
So is he right about Uber or will the bet flop?
» Read more about: Why Bill Ackman Bet $2.3 Billion That the Market Is Dead Wrong »
Read More
AMD’s AI Advantage May Just Be Getting Started
While the spotlight often shines brightest on Nvidia, another chipmaker has been clawing its way into the conversation and could soon be in a position to steal the show.
That company is Advanced Micro Devices (NASDAQ: AMD), and it’s gearing up to report second-quarter earnings early next month.
With the stock already up 34% this year,
» Read more about: AMD’s AI Advantage May Just Be Getting Started »
Read MoreThe Ivy
Is This Healthcare Stock Set To Rally?
Eli Lilly has been a frustrating hold so far this year. Shares are slightly down year to date, a rare stumble for a company that has delivered nearly 5x returns over the past five years.
For a stock that’s become a poster child of the weight-loss and diabetes boom, the slowdown in momentum has left investors wondering if the story has run its course.
» Read more about: Is This Healthcare Stock Set To Rally? »
Read MoreThe Spotlight
UPS Stock Is Sinking But This Dividend Giant May Be Poised for a Comeback
United Parcel Service may be a household name, but lately, its stock performance has left investors anything but comforted.
UPS started 2025 on the back foot. In the first quarter, revenue slipped slightly, margins were underwhelming, and earnings per share were up just 4% year-over-year. What’s more telling? U.S. daily delivery volumes were down by around the same amount.
» Read more about: UPS Stock Is Sinking But This Dividend Giant May Be Poised for a Comeback »
Read MoreThe Daily
Stock market today: Dow, S&P 500, Nasdaq futures rise as November kicks off with earnings, AI, Fed in focus
US stock futures rose Monday morning as Wall Street looked to extend last month’s momentum into November.
S&P 500 futures (ES=F) and Nasdaq 100 futures (NQ=F) made gains of 0.3% and 0.6%, respectively. Dow Jones Industrial Average futures (YM=F) added about 0.1%.
Wall Street is looking to keep up a rally that raged throughout October.